Online citations, reference lists, and bibliographies.
← Back to Search

Cell Specific Cytotoxicity And Uptake Of Graphene Nanoribbons.

Sayan Mullick Chowdhury, G. Lalwani, Kevin Zhang, Jeong-Yoon Yang, Kayla Neville, B. Sitharaman
Published 2013 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
The synthesis of oxidized graphene nanoribbons (O-GNR) via longitudinal unzipping of carbon nanotubes opens avenues for their further development for a variety of biomedical applications. Evaluation of the cyto- and bio-compatibility is necessary to develop any new material for in vivo biomedical applications. In this study, we report the cytotoxicity screening of O-GNRs water-solubilized with PEG-DSPE (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)]), using six different assays, in four representative cell lines; Henrietta Lacks cells (HeLa) derived from cervical cancer tissue, National Institute of Health 3T3 mouse fibroblast cells (NIH-3T3), Sloan Kettering breast cancer cells (SKBR3) and Michigan cancer foundation-7 breast cancer cells (MCF7). These cell lines significantly differed in their response to O-GNR-PEG-DSPE formulations; assessed and evaluated using various endpoints (lactate dehydrogenase (LDH) release, cellular metabolism, lysosomal integrity and cell proliferation) for cytotoxicity. In general, all the cells showed a dose-dependent (10-400 μg/ml) and time-dependent (12-48 h) decrease in cell viability. However, the degree of cytotoxicity was significantly lower in MCF7 or SKBR3 cells compared to HeLa cells. These cells were 100% viable upto 48 h, when incubated at 10 μg/ml O-GNR-PEG-DSPE concentration, and showed decrease in cell viability above this concentration with ~78% of cells viable at the highest concentration (400 μg/ml). In contrast, significant cell death (5-25% cell death depending on the time point, and the assay) was observed for HeLa cells even at a low concentration of 10 μg/ml. The decrease in cell viability was steep with increase in concentration with the CD(50) values ≥ 100 μg/ml depending on the assay, and time point. Transmission electron microscopy of the various cells treated with the O-GNR solutions show higher uptake of the O-GNR-PEG-DSPEs into HeLa cells compared to other cell types. Additional analysis indicates that this increased uptake is the dominant cause of the significantly higher toxicity exhibited by HeLa cells. The results suggest that water-solubilized O-GNR-PEG-DSPEs have a heterogenous cell-specific cytotoxicity, and have significantly different cytotoxicity profile compared to graphene nanoparticles prepared by the modified Hummer's method (graphene nanoparticles prepared by oxidation of graphite, and its mechanical exfoliation) or its variations.
This paper references
10.1021/JA01539A017
Preparation of Graphitic Oxide
W. S. Hummers (1958)
10.1016/S0887-2333(97)00083-0
An in vitro approach to the evaluation of repeat exposure in the prediction of toxicity.
R. Clothier (1997)
10.1126/SCIENCE.1102896
Electric Field Effect in Atomically Thin Carbon Films
K. Novoselov (2004)
10.1002/CHIN.200408296
Functionalized Fullerenes in Water. The First 10 Years of Their Chemistry, Biology, and Nanoscience
E. Nakamura (2004)
10.1016/J.ADDR.2006.09.015
Carbon nanotubes as nanomedicines: from toxicology to pharmacology.
L. Lacerda (2006)
10.1038/nprot.2006.339
Clonogenic assay of cells in vitro
N. Franken (2006)
10.1166/JBN.2007.043
Gadofullerenes and Gadonanotubes: A New Paradigm for High-Performance Magnetic Resonance Imaging Contrast Agent Probes
B. Sitharaman (2007)
10.1038/NMAT1849
The rise of graphene.
Andre K. Geim (2007)
10.1038/nmat1967
Detection of individual gas molecules adsorbed on graphene.
F. Schedin (2007)
10.1002/smll.200700595
Cytotoxicity of nanoparticles.
Nastassja A Lewinski (2008)
10.1007/S12274-008-8021-8
Nano-graphene oxide for cellular imaging and drug delivery
X. Sun (2008)
10.1002/smll.200700754
Adsorption of essential micronutrients by carbon nanotubes and the implications for nanotoxicity testing.
Lin Guo (2008)
10.1016/j.biomaterials.2008.04.023
On the mechanisms of biocompatibility.
D. Williams (2008)
10.1143/APEX.1.034007
Inter-Layer Screening Length to Electric Field in Thin Graphite Film
H. Miyazaki (2008)
On the mechanisms of biocompatibility. Biomaterials 2008;29: 2941e53
DF Williams (2008)
10.1007/S12274-009-9009-8
Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery
Zhuang Liu (2009)
10.1021/mp800197v
Affinity of drugs and small biologically active molecules to carbon nanotubes: a pharmacodynamics and nanotoxicity factor?
John Liu (2009)
10.1038/nature07872
Longitudinal unzipping of carbon nanotubes to form graphene nanoribbons
D. V. Kosynkin (2009)
10.1063/1.3079663
Logic gates with a single graphene transistor
R. Sordan (2009)
10.1039/B821416F
Superparamagnetic graphene oxide–Fe3O4nanoparticles hybrid for controlled targeted drug carriers
X. Yang (2009)
10.1093/mutage/gep010
Confounding experimental considerations in nanogenotoxicology.
S. Doak (2009)
10.1021/nn100728p
Large scale pattern graphene electrode for high performance in transparent organic single crystal field-effect transistors.
Wei Liu (2010)
10.1039/c1nr10172b
Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene.
A. Sasidharan (2011)
10.1126/science.1204428
Wafer-Scale Graphene Integrated Circuit
Y. Lin (2011)
10.1021/nn201092p
Thrombus inducing property of atomically thin graphene oxide sheets.
S. Singh (2011)
10.7150/THNO/V01P0240
Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy
P. Huang (2011)
10.1016/j.toxlet.2010.11.016
In vitro toxicity evaluation of graphene oxide on A549 cells.
Yanli Chang (2011)
10.1007/s11671-010-9751-6
Biocompatibility of Graphene Oxide
K. Wang (2011)
10.1021/nn1024303
In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice.
Kai Yang (2011)
Wafer-scale graphene integrated circuit. Science 2011;332:1294e7
Y-M Lin (2011)
10.1371/journal.pone.0038185
Physicochemical Characterization, and Relaxometry Studies of Micro-Graphite Oxide, Graphene Nanoplatelets, and Nanoribbons
Bhavna S. Paratala (2012)



This paper is referenced by
10.1007/s00894-021-04737-w
Scavenging of OH and OOH radicals by polyradicals of small polycyclic aromatic hydrocarbons
Amarjeet Yadav (2021)
10.3390/APP11020614
A Review on Recent Advancements of Graphene and Graphene-Related Materials in Biological Applications
Federica Catania (2021)
10.1016/j.bioactmat.2020.08.016
Poly(lactic-co-glycolic acid)-based composite bone-substitute materials
Duoyi Zhao (2021)
10.2147/IJN.S249712
Functionalized Graphene Platforms for Anticancer Drug Delivery
S. Sattari (2021)
10.1177/0021998320983870
Microstructured poly(ether-ether-ketone)-hydroxyapatite composites for bone replacements
P. Venkatraman (2021)
10.1007/S00044-021-02714-9
Loading harmine on nanographene changes the inhibitory effects of free harmine against MCF-7 and fibroblast cells
newsha mortazavi (2021)
10.1007/s11356-021-13058-7
Pristine graphene and graphene oxide induce multi-organ defects in zebrafish (Danio rerio) larvae/juvenile: an in vivo study
B. Manjunatha (2021)
10.1177/03635465211023183
Intra-articular Injection of Kartogenin-Enhanced Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis in a Rat Model
W. Zeng (2021)
10.1016/J.IMPACT.2021.100292
Quantifying respiratory tract deposition of airborne graphene nanoplatelets: The impact of plate-like shape and folded structure
H. Gao (2021)
10.3390/ma14051059
Advances in Drug Delivery Nanosystems Using Graphene-Based Materials and Carbon Nanotubes
J. Jampílek (2021)
10.1016/J.COLSURFA.2021.126971
Folic acid-conjugated raloxifene-loaded graphene-based nanocarrier: Fabrication, characterization and antitumor screening
A. Lila (2021)
10.1016/j.msec.2021.111921
Insights of doxorubicin loaded graphene quantum dots: Synthesis, DFT drug interactions, and cytotoxicity.
A. M. Sawy (2021)
10.1039/d1tb00871d
Recent advances in graphene nanoribbons for biosensing and biomedicine.
Siyu Luo (2021)
10.1007/s40097-021-00444-3
Graphene and its derivatives: understanding the main chemical and medicinal chemistry roles for biomedical applications
Tais Monteiro Magne (2021)
10.1021/acsbiomaterials.9b01897
Cytotoxicity of Formulated Graphene and Its Natural Rubber Nanocomposite Thin Film in Human Vaginal Epithelial Cells: An Influence of Noncovalent Interaction
Thenmozhi Sukumar (2020)
10.1007/s42823-020-00125-1
A review on graphene nanoribbons for advanced biomedical applications
Pravin Shende (2020)
10.1021/acs.chemrestox.9b00391
Mechanistic Insights into the Cytotoxicity of Graphene Oxide Derivatives in Mammalian Cells.
Phillip Lu (2020)
10.1021/acsbiomaterials.9b01473
Preparation of Polyurethane-Graphene Nanocomposite and Evaluation of Neurovascular Regeneration.
Tsung-Han Lee (2020)
10.1016/b978-0-12-821959-1.00016-7
Toxicity of carbon nanomaterials
S. Ray (2020)
10.1021/acsami.9b20070
Lipid-Functionalized Graphene Loaded with hMnSOD for Selective Inhibition of Cancer Cells.
Megan Farell (2020)
10.1016/b978-0-12-819943-5.00004-x
Standard biological assays to estimate nanoparticle toxicity and biodistribution
Juhi Shah (2020)
10.1038/s41467-020-17301-6
A high performance wearable strain sensor with advanced thermal management for motion monitoring
Cenxiao Tan (2020)
10.1016/j.jconrel.2020.06.034
Graphene nanoribbons: A promising nanomaterial for biomedical applications.
Asha P Johnson (2020)
10.1039/d0tc02429e
Harnessing biological applications of quantum materials: opportunities and precautions
Mani Modayil Korah (2020)
10.1073/pnas.1919921117
Remote nongenetic optical modulation of neuronal activity using fuzzy graphene
Sahil K. Rastogi (2020)
10.3389/fmicb.2020.00790
Autophagy Participates in Lysosomal Vacuolation-Mediated Cell Death in RGNNV-Infected Cells
Y. Huang (2020)
10.21203/rs.3.rs-115775/v1
Graphene Nano-Fiber Composites for Enhanced Neuronal Differentiation of Human Mesenchymal Stem Cells†
Sujata Mohanty (2020)
10.1016/j.ajps.2020.11.004
Use of graphene-based materials as carriers of bioactive agents
Wing‐Fu Lai (2020)
10.1016/bs.coac.2020.08.011
Safety and toxicity concerns of graphene and its composites
Arun Koyyada (2020)
10.1007/978-981-15-2233-8_1
Introduction of Graphene-Based Nanomaterials
Je-Min Yoo (2020)
10.36347/sajp.2020.v09i09.004
A Brief Review on the Synthesis, Cytotoxixity, Bioavailability and Various Applications of Graphene Nanomaterials
Saurabh Savita (2020)
10.32776/REVBIOMED.V30I3.708
Evaluación de la citotoxicidad de nanogeles de polivinilpirrolidona (PVP) en fibroblastos murinos
Laura Garcia-Rodriguez (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar